IB
Irina Bulatovic
View Irina's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
Oct 2023 - Present · 1 years and 2 months
N/A
May 2018 - Oct 2023 · 5 years and 5 months
N/A
Sep 2017 - May 2018 · 8 months
Company Details
51-200 Employees
Alkaloid AD Skoplje je kompanija koja više od osam I po decenija posluje u oblasti proizvodnje lekova, kozmetičkih i hemijskih proizvoda kao i prerade biljnih sirovina. Alkaloid je prisutan na srpskom tržištu od 1946. godine. U Beogradu, 1992. godine osnovan je Alkaloid Srbija, sa jasnom misijom u svom poslovanju, misijom stalnog rada na poboljšanju zdravlja ljudi i kvaliteta njihovih života. Jasni ciljevi, apsolutna posvećenost i vizija opšteg dobra doprineli su da Alkaloid Srbija kontinuirano raste i razvija se. Alkaloid u Srbiji danas poseduje i sopstvenu proizvodnju, laboratoriju i veledrogeriju koje posluju u okviru Alkaloid d.o.o. i Alkaloid Veledrogerija d.o.o. Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field of manufacturing drugs, cosmetic and chemical products and processing botanical raw materials. Alkaloid has been present on the Serbian market since 1946. In Belgrade, in 1992, Alkaloid Serbia was founded, with a clear mission in its business, the mission of constant work to improve people's health and the quality of their lives. Clear goals, absolute dedication and a vision of the common good contributed to Alkaloid Serbia continuously growing and developing. Today, Alkaloid in Serbia also has its own production, laboratory and wholesale pharmacy, which operate within Alkaloid d.o.o. and Alkaloid Veledrogerija d.o.o.
Year Founded
1992
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing
HQ Location
Prahovska 3 Belgrade, 11000, RS
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Irina Bulatovic in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.